Your browser doesn't support javascript.
loading
Therapeutic potential of combination therapy of soluble VEGF receptor 1 and conventional chemotherapy for ovarian cancer growth.
Sato, Noriko; Kumasawa, Keiichi; Yamashita, Michiko; Miyake, Tatsuya; Nakamura, Hitomi; Kimura, Tadashi.
Afiliação
  • Sato N; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kumasawa K; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Yamashita M; Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Miyake T; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Nakamura H; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kimura T; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.
J Obstet Gynaecol Res ; 46(4): 636-645, 2020 Apr.
Article em En | MEDLINE | ID: mdl-32022375
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica / Carboplatina / Receptor 1 de Fatores de Crescimento do Endotélio Vascular Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica / Carboplatina / Receptor 1 de Fatores de Crescimento do Endotélio Vascular Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article